Get updates to this list
feed
-
Prescribing of controlled drugs by therapeutic radiographers: further advice
-
Precursor chemical import and export authorisation wallchart
-
Psychoactive substances ban 6 months on: almost 500 arrests and first convictions
-
Further advice on U-47,700, etizolam and other designer benzodiazepines
-
Advice on U-47,700, etizolam and other designer benzodiazepines
-
Letter from Sarah Newton: U-47,700 and designer benzodiazepines
-
Misuse of Drugs Regulations 2001: impact on research
-
Precursor chemical licensing
-
Plant cannabinoids: ACMD report
-
Pregabalin and gabapentin: letter from Sarah Newton to the ACMD
-
Medicines supplementing use of other illicit drugs, says ACMD
-
Diversion & illicit supply of medicines
-
New chair of Advisory Council on the Misuse of Drugs
-
ACMD tells ministers drug-related deaths will continue to rise if treatment programmes are not maintained
-
Reducing opioid-related deaths in the UK
-
Drug and alcohol addiction, and obesity: effects on employment outcomes (independent review)
-
Drug and alcohol addiction, and obesity: effects on employment outcomes
-
Circular 010/2016: a change to the Misuse of Drugs Act 1971
-
'Third generation' synthetic cannabinoids
-
Methiopropamine temporary class drug order: ministerial response
-
Temporary class drug order on methiopropamine
-
Problems for Ageing Drug Users Working Group: public meeting invitation
-
Independent prescribing of controlled drugs by therapeutic radiographers
-
Headshops closed and offenders arrested after 'legal highs' ban
-
New Psychoactive Substances (NPS) resource pack
-
Dienedione and synthetic cannabinoids: letter from Karen Bradley to the ACMD
-
Advisory Council on the Misuse of Drugs recruiting new chair
-
General security guidance for controlled drug suppliers
-
Controlled drugs list
-
Public Health Outcomes Framework
-
Trade in so-called 'legal highs' now illegal
-
Circular 004/2016: Psychoactive Substances Act 2016
-
Psychoactive Substances Act: guidance for retailers
-
Psychoactive Substances Act: guidance for researchers
-
Methylphenidate-based NPS: letter from Karen Bradley to the ACMD
-
Advice on the anticonvulsant drugs Pregabalin and Gabapentin
-
Advice on the steroid Dienedione
-
Public Health Outcomes Framework 2013 to 2016
-
Circular 028/2015: Misuse of Drugs Act 1971 (Temporary Class Drug) (No. 3) Order 2015
-
Ministerial response to ACMD advice on temporary control under the Misuse of Drugs Act 1971